Alexion Pharmaceuticals, Inc. · 4 days ago
Head of Data Science and Advanced Analytics , US Commercial
Boston, Massachusetts, United States of America
Full-time
Hybrid
Director/Executive
$218K/yr - $327K/yr
15+ years expAlexion Pharmaceuticals, Inc. is a leader in the healthcare sector focused on rare diseases. As the Head of Data Science and Advanced Analytics for the US Commercial division, you will develop and lead strategies that leverage data-driven insights to enhance commercial effectiveness, patient engagement, and market expansion.
BiotechnologyHealth CareMedicalTherapeutics
Responsibilities
Develop and lead the execution of a data science and advanced analytics strategy tailored to the US Commercial business, with a focus on maximizing field effectiveness, patient identification, customer engagement, and commercial success in rare and specialty disease markets
Partner with US Commercial leadership and cross-functional collaborators to ensure alignment of analytics priorities
Drive the adoption of AI, predictive modeling, and advanced insights throughout the commercial division
Coordinate the Center of Excellence's operations involving data science and sophisticated analytics to support US Commercial objectives
Ensure deliverables are timely and meet high-quality standards
Address emerging needs in the market, payer trends, and evolving competition
Continuously improve data pipelines, analytical processes, and reporting tools supporting brand, payer, and field teams
Recruit, mentor, and develop a high-performing, US-focused team, including data scientists and commercial analytics specialists
Foster a culture of innovation, accountability, and business partnership within the CoE, ensuring continuous skills development and team engagement
Serve as the lead interface between the CoE and US Commercial business units, including Brand, Market Access, Patient Services, and Customer Engagement
Translate complex analyses into clear business recommendations and deliver presentations to US commercial leadership, sales teams, and external partners as needed
Lead building, implementation, and maintenance of advanced analytics models and dashboards to address critical commercial opportunities (e.g., targeting and segmentation, omnichannel marketing analytics, measurement of return on investment, patient journey analysis, and forecasting)
Drive the use of real-world, claims, and distribution data to improve performance in rare disease launches and mature portfolio management
Support data-driven decision making by providing market insights, competitive intelligence, and field performance analytics for the US market
Evaluate and deploy innovative analytics technologies, AI/ML platforms, and advanced data tools that give US Commercial teams a competitive advantage
Monitor commercial analytics trends and practices in the US healthcare market and integrate outstanding solutions
Define and track critical metrics measuring CoE impact within US Commercial performance (e.g., sales growth, market penetration, HCP engagement, launch excellence)
Deliver actionable dashboards, reports, and insights to multiple US Commercial collaborators and regional representatives
Qualification
Required
Master's or Ph.D. in Data Science, Statistics, Computer Science, Business Analytics, or a related quantitative field
15+ years' experience in data science, advanced analytics, or commercial analytics roles, including at least 7 years in a senior/leadership capacity with a focus on US Commercial operations in healthcare, biotech, or pharmaceuticals
Deep proficiency in commercial data science and analytics, including statistical modeling, machine learning, segmentation, and forecasting (Python, R, SQL, etc.)
Hands-on experience with commercial analytics and visualization tools (e.g., Qlik, Power BI, Tableau, Veeva, Databricks)
Expertise working with US commercial data assets (claims, prescription, distribution, CRM, real-world data, patient support)
Demonstrated ability to build and lead US-focused analytics teams
Strong interpersonal, influencing, and communication skills; able to effectively present analytics to commercial executives and field teams
Proven record of change management and building commercial analytics capabilities
Advanced business acumen, with the ability to turn US commercial challenges into actionable analytics projects and insights that fuel growth and performance
Ability to work in a fast-paced, dynamic environment
Strong leadership and team management capabilities
Experience, working in the pharma or biotech sectors, preferably working within or with the Commercial team
Knowledge of Syndicated Claims data, Lab data (IQVIA LAAD, Symphony, Specialty Pharmacy/Specialty Distribution)
Deep understanding of the US pharmaceutical/biotech commercial landscape, including field force dynamics, market access, specialty distribution, and key challenges in rare disease markets
Ability to set a compelling vision for advanced analytics as a business driver within the US Commercial environment
Ability to engage and partner across commercial, brand, patient services, and market access teams
Commitment to ethical data practices, patient privacy, and compliance with US regulatory standards (HIPAA, etc.)
Preferred
Proven experience in performing analytics related to US commercial activities for rare or specialty diseases is highly preferred
Benefits
Short-term incentive bonuses
Equity-based awards for salaried roles
Commissions for sales roles
Qualified retirement programs
Paid time off (i.e., vacation, holiday, and leaves)
Health, dental, and vision coverage
Company
Alexion Pharmaceuticals, Inc.
Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community.
1001-5000 employees
H1B Sponsorship
Alexion Pharmaceuticals, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (49)
2024 (57)
2023 (51)
2022 (29)
2021 (27)
2020 (17)
Funding
Current Stage
Public CompanyTotal Funding
$5.8M2020-12-12Acquired
1999-02-12Post Ipo Equity· $5.8M
1996-02-29IPO
Leadership Team
Frederic Chereau
SVP, Strategy and Business Development
Imran Shakur
Director, IRT and Technology Lead
Recent News
BioWorld Financial Watch
2026-01-17
bloomberglaw.com
2025-12-20
Company data provided by crunchbase